新诊断肺癌和结直肠癌患者的乳腺癌筛查:基于人群的利用情况研究
该研究评估了2000至2011年间在SEER登记处登记的≥67岁女性医保受益人(新诊断肺癌或结直肠癌)与无癌对照者的乳腺癌筛查利用情况。共纳入104,164例病例和104,164例对照,结果显示肺癌或结直肠癌患者接受至少一次筛查性乳腺X线摄影的比例为22%,低于对照组的26%(OR 0.80;95%CI 0.78-0.82)。分层分析显示,早期癌症患者与对照组的筛查率相似,但晚期癌症患者中仍有8%继续接受筛查。
要点
- 肺癌或结直肠癌患者筛查性乳腺X线摄影利用率低于无癌对照(22% vs 26%,OR 0.80)。
- 肺癌患者筛查率低于对照(17% vs 23%,OR 0.63),结直肠癌患者与对照无显著差异(28% vs 29%,OR 0.98)。
- 晚期癌症患者筛查率低于对照(8% vs 18%,OR 0.33),但仍有8%接受筛查。
核心结论
- 早期癌症医保受益人的筛查性乳腺X线摄影利用率与无癌对照相似;大多数晚期癌症患者适当地未进行筛查,但仍有小部分(8%)继续筛查。
研究设计与样本
- 基于人群的回顾性队列研究,利用SEER登记处和Medicare数据,纳入2000至2011年间诊断的104,164例女性肺癌或结直肠癌患者(48%结直肠癌,52%肺癌;30%晚期)和按年龄、种族、登记地区及随访时间个体匹配的104,164例无癌对照,随访2年。
诊断标准与关键数值
- 筛查利用定义为随访期间至少一次筛查性乳腺X线摄影的女性百分比。
- 总体:病例组22% vs 对照组26%(OR 0.80;95%CI 0.78-0.82)。
- 结直肠癌:病例组28% vs 对照组29%(OR 0.98;95%CI 0.95-1.01)。
- 肺癌:病例组17% vs 对照组23%(OR 0.63;95%CI 0.60-0.65)。
- 晚期癌症:病例组8% vs 对照组18%(OR 0.33;95%CI 0.31-0.35);早期癌症:病例组30% vs 对照组30%(OR 1;95%CI 0.97-1.02)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess breast cancer screening utilization in Medicare beneficiaries with colorectal and lung cancer versus cancer-free controls.
METHODS: Female fee-for-service Medicare beneficiaries who were ≥67 years old and diagnosed with lung or colorectal cancer between 2000 and 2011 and who reported to a Surveillance, Epidemiology, and End Results (SEER) registry (case group) were followed for 2 years after their diagnoses, unless death, a diagnosis of breast cancer, or the end of 2013 came first. A similar number of cancer-free controls were individually matched to cases by age, race, registry region, and follow-up time. Screening utilization was defined as the percentage of women with ≥1 screening mammogram during follow-up.
RESULTS: Overall, 104,164 cases (48% colorectal, 52% lung; 30% advanced cancer) and 104,164 controls were included. Among women with lung or colorectal cancer, 22% underwent ≥1 screening mammogram versus 26% of controls (odds ratio [OR] 0.80; 95% confidence interval [CI] 0.78-0.82). Stratified by cancer type, 28% of colorectal cancer cases versus 29% of controls (OR 0.98; 95% CI 0.95-1.01) and 17% of lung cancer cases versus 23% of controls (OR 0.63; 95% CI 0.60-0.65) received ≥1 mammogram. When stratified by stage, 8% with advanced cancer versus 18% of controls (OR 0.33; 95% CI 0.31-0.35) and 30% with early-stage cancer versus 30% of controls (OR 1; 95% CI 0.97-1.02) underwent ≥1 mammogram.
CONCLUSION: Screening mammography utilization rates are similar between Medicare beneficiaries with early-stage cancer versus controls. Although the majority of patients with advanced-stage cancer appropriately do not pursue screening mammography, a small number (8%) continue with screening.
引用
- Sadigh G, Carlos RC, Ward KC, et al. Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of Utilization. J Am Coll Radiol. 2017. PMID: 28325489. doi:10.1016/j.jacr.2017.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。